Core Viewpoint - Vincerx Pharma, Inc. is urging stockholders to vote for the Dissolution Proposal to maximize potential distributions and minimize ongoing costs [2][5]. Group 1: Dissolution Proposal - The Special Meeting of Stockholders to consider the Dissolution Proposal has been adjourned to July 16, 2025, to allow more time for soliciting votes [1]. - The board of directors unanimously recommends that stockholders vote for the Dissolution Proposal, emphasizing its importance for potential value distribution [2]. - Delaying the approval of the Dissolution Proposal could lead to increased operating costs, reducing the likelihood of any distributions to stockholders [2][5]. Group 2: Voting Process - Stockholders are encouraged to vote immediately, as every vote is crucial for the proposal to pass [2][3]. - Voting can be done easily via phone or internet, with specific instructions provided for participation [6]. Group 3: Financial Implications - Approval of the Dissolution Proposal may allow stockholders to recognize capital losses for tax purposes if they receive less than their tax basis in shares [5]. - The company is hopeful that cash will be available for distribution to stockholders, but further delays could jeopardize this possibility [5].